Are There Subtypes of IMHA In Dogs?
Researchers will study whether there are subtypes of IMHA and whether those subtypes have different prognoses and optimal therapy.
Displaying 1 - 7 of 199 Results
Finding Better Therapies for Dogs with IMHA
Researchers will assess how the immune system goes wrong in dogs with IMHA, and the team will study how individual dogs respond to medications available for treatment.
Studying the Effect of Second- and Third-Hand Smoke on Cancer Risk in Golden Retrievers
Researchers will look for genetic changes associated with cancer risk in golden retrievers exposed to cigarette smoke.
Can Trained Bio-Detection Dogs Diagnose Hemangiosarcoma?
Researchers will evaluate if trained bio-detection dogs can diagnose hemangiosarcoma from a blood sample.
Studying Genetic Variants and Other Factors Associated with Lifespan and Cancer Diagnosis in Golden Retrievers
Researchers will look for genetic variants and other factors that favor longevity and minimize cancer risk in golden retrievers.
Assessing Residual Cancer Cells in Aggressive T-Cell Lymphoma
Researchers will develop and validate a novel molecular tool to assess residual cancer cell levels in dogs with aggressive T-cell lymphoma to help improve treatment and disease monitoring.
Generating T Cells for Canine Cancer Cell Therapies
Researchers will create a new method to expand immune cell production for cancer cell therapies for dogs.